BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27461829)

  • 1. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
    Wang L; Lin D; Fu Y; Lai M
    Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
    Yang W; Wang Y; Wang W; Chen Z; Bai G
    Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    van der Waals LM; Borel Rinkes IHM; Kranenburg O
    PLoS One; 2018; 13(10):e0205536. PubMed ID: 30308036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.
    Kahlert C; Gaitzsch E; Steinert G; Mogler C; Herpel E; Hoffmeister M; Jansen L; Benner A; Brenner H; Chang-Claude J; Rahbari N; Schmidt T; Klupp F; Grabe N; Lahrmann B; Koch M; Halama N; Büchler M; Weitz J
    Ann Surg Oncol; 2012 Dec; 19(13):4193-201. PubMed ID: 22878609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of ALDH1A1 expression predict metastasis and poor outcome of colorectal carcinoma.
    Xu SL; Zeng DZ; Dong WG; Ding YQ; Rao J; Duan JJ; Liu Q; Yang J; Zhan N; Liu Y; Hu QP; Zhang X; Cui YH; Kung HF; Yu SC; Bian XW
    Int J Clin Exp Pathol; 2014; 7(6):2976-86. PubMed ID: 25031716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
    Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
    J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
    Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.
    Bartley AN; Parikh N; Hsu CH; Roe DJ; Buckmeier JA; Corley L; Phipps RA; Gallick G; Lance P; Thompson PA; Hamilton SR
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1162-70. PubMed ID: 24008128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
    Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
    Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
    Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas.
    Redondo M; Rodrigo I; Alcaide J; Tellez T; Roldan MJ; Funez R; Diaz-Martin A; Rueda A; Jiménez E
    Histopathology; 2010 Jun; 56(7):932-6. PubMed ID: 20497247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
    Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
    Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer.
    Wu W; Yang P; Feng X; Wang H; Qiu Y; Tian T; He Y; Yu C; Yang J; Ye S; Zhou Y
    Genes Chromosomes Cancer; 2013 Dec; 52(12):1133-40. PubMed ID: 24123284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer.
    Ahmed MA; Al-Attar A; Kim J; Watson NF; Scholefield JH; Durrant LG; Ilyas M
    J Clin Pathol; 2009 Dec; 62(12):1117-22. PubMed ID: 19946098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
    Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
    Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
    World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.